James Maitland is a visionary in the realm of health technology, specifically focused on the intersection of medical infrastructure and patient-centric digital solutions. With years of experience navigating the complexities of how technology integrates into clinical workflows, he brings a unique perspective on how software must synchronize with human care to provide seamless outcomes. His passion lies in breaking down the silos that prevent data from becoming actionable medical interventions, ensuring that the digital tools we use in our daily lives—from wearables to AI assistants—actually serve the patient’s clinical needs rather than just providing a mountain of unorganized information. By looking at the systemic challenges of the current healthcare landscape, Maitland helps us understand the profound shift toward a future where “online-first” is the standard for medical entry points.
The following discussion explores the critical transition toward consumer-mediated health platforms where patients take genuine ownership of their medical records and care journeys. A central theme is the collaboration between data-rich identity platforms and clinical delivery networks to eliminate the traditional friction found in virtual health settings. The conversation highlights the emergence of a “clinical action layer” that moves beyond simple data visualization or AI querying to direct, evidence-based medical outcomes, such as prescription management, lab interpretation, and chronic condition monitoring. Furthermore, we delve into how massive infrastructure projects are allowing retailers and tech-native companies to bypass years of development to launch sophisticated health services in mere weeks, ultimately shortening the 26-day average wait time for primary care and placing the power back into the hands of the consumer.
Large Language Models and AI chatbots are rapidly becoming the primary digital front door for patients seeking health information, but how do we move beyond simple queries to actual clinical results?
The shift we are seeing is truly a tipping point where platform LLMs have become the digital front door of healthcare almost overnight. While it is incredible that a patient can now query their health record through a tool like ChatGPT, the experience often ends in a frustrating “dead end” where the patient has insights but no clear path to follow. They might learn they have an evidence-based medicine gap or a lapse in medication, but they are still left to navigate a fragmented system to fix it. We are finally building the infrastructure to bridge that gap, connecting those AI-driven insights to a “clinical action layer” that handles the heavy lifting of prescribing, pharmacy coordination, and follow-up. This means the patient is no longer left to figure it out themselves once they have the information at their fingertips; the system actually closes the loop from data to care. It transforms a simple conversation with an AI into a tangible medical outcome, such as a titrated medication or a lab order, without the patient ever feeling the friction of the underlying bureaucracy.
With the partnership between Wheel and b.well, how does the integration of consumer-authorized health records change the way a clinician interacts with a patient during a virtual visit?
For too long, virtual care has been limited by a lack of historical context, forcing clinicians to work with a snapshot rather than a full picture. By pulling in a patient’s longitudinal health record—which includes data from over 2.2 million providers and 320 health plans—the clinician suddenly has a high-definition view of the person’s medical journey. Imagine a weight management consultation where the provider can instantly see an A1C lab result that is out of range; they can now treat that patient for more than just their initial concern, perhaps screening for Type 2 diabetes or other cardiometabolic issues. This level of insight significantly reduces the risk of medical errors and allows for a much more sophisticated, longitudinal approach to care rather than a one-off transaction. It gives the clinician the confidence of a physical office visit combined with the speed and accessibility of a digital platform, ensuring that every decision is backed by a comprehensive data trail.
The traditional timeline for scaling a virtual care program can be incredibly slow, so how is new infrastructure allowing companies to bypass these historical roadblocks?
Historically, a company looking to launch a nationwide telehealth service would be looking at a 15-month development cycle just to get the basic clinical and operational infrastructure off the ground. That long lead time is a death sentence in a market that moves as fast as AI-driven healthcare is moving today. By using a pre-wired, white-label infrastructure, companies can now scale these services in a matter of weeks rather than years. This “easy button” for virtual care allows retailers, pharma companies, and even AI-native startups to plug into a nationwide clinician network and a robust pharmacy workflow immediately. It removes the need for these organizations to build their own clinician operations or prescribing layers from scratch, letting them focus entirely on the consumer experience. We are essentially democratizing the ability to provide high-quality medical care, allowing any brand with a consumer base to become a point of care.
What role does data identity and secure access play in ensuring that this new consumer-driven model remains safe and trustworthy for the average user?
Trust is the bedrock of healthcare, and without a secure way to verify who is accessing and sharing data, the entire system falls apart. We are seeing a move toward using secure identity platforms, like CLEAR’s IAL2 credentials, to ensure that when a patient authorizes the exchange of their medical records, it is handled with the highest level of security. This consumer-mediated access is a major shift from the old system-centric environment where data was locked away in silos that patients couldn’t reach. By empowering the consumer to verify their identity and control their own data flow across labs, health plans, and providers, we create a secure exchange that feels as natural as checking into an airport. It’s about creating a reusable digital credential that allows the patient to move through the healthcare ecosystem without having to re-verify or re-submit their history at every single turn.
As retail giants and pharmacies become more involved in the direct-to-consumer health space, how does this infrastructure support the “next version” of healthcare that we are seeing today?
We are seeing a massive shift where healthcare is beginning online and staying online through the entire care journey, and this is perfectly illustrated by platforms like Walmart’s Better Care Services. These retailers are becoming vital care access points because they are meeting patients where they already spend their time and money. The infrastructure behind the scenes supports everything from cardiometabolic health and GLP-1 care to urgent care and Medicare Bridge models, all delivered through a scalable B2B or DTC framework. This allows a patient to interact with their healthcare earlier and more frequently because the barriers to entry—like the 26-day wait for a primary care appointment—are completely removed. It turns a trip to a retail website or an app into a comprehensive medical experience that covers intake, diagnosis, prescribing, and even outcome measurement.
How does the “clinical action layer” specifically address the problem of data being siloed in apps and wearables without a clear path to medical treatment?
The reality today is that many people have incredible amounts of data from their watches, rings, and apps, but that data is functionally useless if it doesn’t reach a clinician who can act on it. The “clinical action layer” is designed to absorb all of that context—the wearable data, the lab results, the patient-reported symptoms—and synthesize it into a clinician summary that highlights the next best action. Instead of a patient showing up to a doctor with a list of raw numbers that the provider doesn’t have time to review, the system pre-processes that information to determine if a medication change or a specific lab test is necessary. It turns “context generation” into “clinical delivery,” ensuring that the insight that a patient’s heart rate is elevated or their glucose is spiking leads directly to a medical intervention. This effectively closes the loop, so the patient isn’t just staring at a dashboard but is actually receiving the care those numbers indicate they need.
What is your forecast for the evolution of virtual-first care models over the next five years?
I believe we are moving toward a reality where the “digital front door” becomes the only door for the vast majority of non-emergency medical interactions. In the next five years, the distinction between “virtual care” and “real care” will disappear as AI becomes the standard interface through which we manage our longitudinal health records. We will see a system that is almost entirely consumer-mediated, where patients use AI-powered tools to monitor their health in real-time, with clinical action layers working silently in the background to adjust treatments before a crisis occurs. The average wait time for an appointment will plummet from weeks to minutes, and the focus will shift from treating acute illness to maintaining wellness through continuous, data-driven monitoring. Ultimately, healthcare will become an embedded, proactive part of our daily digital lives, rather than a destination we only visit when something is wrong.
